Media
Latest News
Washington, D.C. – On December 19, 2023, the Drug Enforcement Administration (DEA) informed members of Congress that it is now conducting its official review of the Department of Health and Human Services’ (HHS) recommendation to reschedule marijuana from a Schedule I to Schedule III drug under the Controlled Substances Act (CSA).
ICYMI: Congressman Harris Pens Op-Ed On The Need For Congress To Address SNAP’s Contribution To Poor Health |
Washington, D.C. – The FDA is set early this year to promote their Chief Scientist, Dr. Namandjé Bumpus, to the #2 position of “principal deputy commissioner” at the FDA. It has been discovered that while at Johns Hopkins, Dr.
Washington, D.C. – Congressman Andy Harris, M.D., will hold a public event on January 20, 2024, at 2:00 PM EST, on the effects offshore wind industrialization is having on our environment, marine life, and economy. |
Washington, D.C. – Congressman Andy Harris, M.D. (MD-01) issued the following statement today while visiting the U.S. Southern Border in Eagle Pass, TX. along with House Speaker, Mike Johnson and nearly 60 other House Republican colleagues.
Washington, D.C. – Congressman Andy Harris, M.D. (MD-01), will hold a telephone town hall tonight reaching out to more than 60,000 constituents in the First District.Congressman Harris’s office will call out to constituents in the Harford County and Upper Shore region.
Washington, D.C.–Congressman Andy Harris M.D. (MD-01), Chairman of the House Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies released the following statement on the Fourth Circuit Court of Appeals decision on the Maryland handgun training law.
Statement From Congressman Harris: